Circulating Tumor Cell (CTC) Diagnostics Market to Reach

ROCKVILLE, Md., Feb. 15 29, 2022 (GLOBE NEWSWIRE) — Circulating tumor cells (CTCs) are a hot topic of oncology conferences and research due to their enormous potential in the diagnosis and treatment of cancer. The amount of research that CTCs have been invested in signals the lucrative growth prospects of the CTC diagnostics market, which is expected to surpass the valuation of over US$9.5 billion by 2030 – projects a recent study published by Fact. MR.

The study highlights the potential of CTC enrichment technologies in the field of CTC diagnostics and remains optimistic about the profitability of investments made in this field. The potential of CTC diagnostics is not limited to diagnosing the presence of a tumor, but it also goes beyond to help find the basic information about that tumor. In the years to come, the importance of circulating tumor cell (CTC) diagnosis in cancer therapies and treatment is expected to remain substantial and the market will witness astonishing growth over the next decade, according to the Fact.MR study.

Circulating Tumor Cell Diagnostics Market by Application
CTC diagnostic tests and equipment are widely used in a wide range of applications with the ultimate goal of achieving higher levels of accuracy and reliability in cancer cell detection. Major applications of CTC diagnostics include cancer stem cell research, EMT biomarker development, and tumorigenesis research.

For more market insights, request a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=5510

Among all these applications, the adoption of CTC diagnostics in cancer stem cell research is expected to remain very high. Cancer stem cells are considered by researchers to be among the most promising therapeutic targets in cancer treatments and are of great importance in the clinical diagnosis of tumours.

As cancer stem cells are known to have a strong tendency for regeneration and self-renewal, they are known to be the main cause of tumorigenesis. Thus, the applications of CTC diagnostics in the field of cancer stem cell research will play a vital role in the growth of the market.

Impact of COVID-19
The unprecedented condition caused by the rapid spread of the novel coronavirus has caught many countries as well as health organizations off guard. Although the world has reached the start of 2021, the negative impacts of COVID-19 do not appear to be diminishing as the new mutated variant of the virus is spreading rapidly.

In such situations, the operations of many endoscopy units have been severely restricted in many countries, limiting the activities of urgent procedures and diagnostic tests, which mainly impacts the growth prospects of the CTC diagnostics market. .

Regional outlook
The North American CTC diagnostics market accounts for nearly one-third of global market revenue, leading the pack in regional markets in this landscape.

The major growth driver of the North American CTC diagnostics market is the alarming increase in cancer deaths in the region. According to the American Cancer Society, nearly 1.8 million new cancer cases and over half a million cancer deaths were reported in the United States in 2020.

Current cancer statistics regarding its incidence, survival and mortality in the region are alarming, which has encouraged research in this area.

Furthermore, the convergence of technologies in the field of cancer research has remained very high in the region, which is further driving the growth of the CTC diagnostics market in the region.

Get customization on this report for specific research solutions: https://www.factmr.com/connectus/sample?flag=RC&rep_id=5510

Key Takeaways from the CTC Diagnostics Market Report

• The CTC diagnostics market has surpassed the US$6 billion mark as it reached the valuation of US$6.3 billion in 2020. The major factor driving the market remains the ongoing research in the field of diagnostics cancer and the growing number of cancers. dead in the world.
• The market is expected to grow exponentially over the next decade as the predicted CAGR is expected to exceed 17% during the forecast period of 2020 to 2030.
• Adoption of CTC enrichment methods is expected to remain significantly high, as the segment is expected to reach a valuation of over US$9.5 billion by the end of the assessment period.
• The North American CTC diagnostics market is expected to lead the regional category with a valuation of over US$2 billion in 2020. With the ongoing cancer research in the region and the growing presence of market leaders, the regional market is expected to secure a third revenue share in the global space.
• Patient appetite for non-invasive diagnostic tests and prognostic tools to predict or detect cancer risk is one of the market growth drivers. Manufacturers should also experiment with CTC detection and analysis technologies to improve the accuracy and reliability of results.

CTC Diagnostics Market: Segmentation
The study offers a detailed estimate and outlook of the CTC diagnostics market based on product, technology, application, sample type, and region.

Product

• Devices and systems
• Kits and reagents
• Other consumables

Technology

• CTC enrichment methods
• CTC detection methods
• CTC analysis

Application

• Cancer stem cell research
• Development of EMT biomarkers
• Tumorigenesis research
• Others

Typical sample

Request a methodology and get an overview of our expertise: https://www.factmr.com/connectus/sample?flag=RM&rep_id=5510

What are the key strategies of the Circulating Tumor Cells market players?
Key CTC diagnostics market players include

• Qiagen
• Bio-Techne Corporation
• Janssen Diagnostics LLC
• Advanced Cell Diagnostics Inc
• Apo Cell Inc
• Celltraffix Inc.
• Aviva Biosciences
• Biocept inc.
• Clearbridge Biomedical
• Fluxion Biosciences
• IVDiagnostics
• Stem Cell Technologies Inc.
• Stemcell Technologies Inc.
• Sysmex company. First

Major market players are increasingly focusing on research and development as innovation remains an integral part of their business strategy to gain an edge in this landscape.

In November 2019, the partnership was announced between Ikonisys Inc. – a cell diagnostics company headquartered in the United States – and Sheba Medical Center – one of the leading hospitals in the Middle East region, based in the metropolitan area of ​​Tel Aviv, Israel – for the development of CTC diagnostic tests that can target specific types of cancer.

Purchase a Premium Copy of CTC Diagnostics Marketplace: https://www.factmr.com/checkout/5510

Explore Fact.MR’s healthcare coverage –

medical camera market– In today’s medicine, medical cameras have become indispensable. Images and videos captured by medical cameras are used in a variety of life science applications that require visual documentation. Microscopy, ophthalmology, pathology, endoscopy, laboratory automation, biomedical research, rheumatology and other specialties use these cameras widely. During the forecast period, steady technical improvements along with increased adoption and application of medical cameras are expected to drive the market boom. Rapid adoption of new equipment, rising healthcare expenditure per capita, and increasing investment in research and development will all contribute to the growth of the market in the North America region.

ENT camera market– Due to its market presence in today’s world, the global ENT camera market is expected to grow at a modest rate throughout the forecast period. However, technological improvements also affecting the ENT camera market, product availability and exposure may be affected. The majority of the increase is due to an increase in the number of ENT cameras used in reported cases; surgical treatments are carried out using ENT cameras in the generic market, and therefore there is fierce competition between local and regional players to develop products that are highly compatible and useful to the majority of consumers.

Medical Device Contract Manufacturing Market– Contract manufacturing of medical devices for orthopedic therapy continues to impact the growth plans of companies in the market, accounting for more than a quarter of total revenue. The growing market share is expected to come from increased application in the manufacture of cardiovascular devices. The increase in the elderly population suffering from conditions such as arthritis and the growing need for personalized devices are expected to stimulate the emergence of new competitors focusing in particular on orthopedic devices. Additionally, the increasing prevalence of diabetes, cardiovascular disease and obesity in developing countries is propelling the Asia-Pacific market forward.

About Us:
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide range – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.

Contact:
USA Sales Office:
11140 Rockville Pike
Office 400
Rockville, MD 20852
United States
E-mail: [email protected]
Tel: +1 (628) 251-1583